GlassScriptPhysician profile
Eric S Hollabaugh
NPI 1497749824
$1,382.00
in general payments reported to CMS, 2019-2025
14 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.27 · 2020: $355 · 2021: $205 · 2022: $70.56 · 2023: $50.67 · 2024: $311 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $546.31 | 2020-2021 | |
| Kerecis Limited | $231.45 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $145.93 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $109.02 | 2025 | Cabtreo |
| Leo Pharma INC. | $66.94 | 2025 | Adbry |
| Sun Pharmaceutical Industries INC. | $53.83 | 2019-2023 | Ilumya |
| Bioventus LLC | $53.52 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $50.31 | 2024-2025 | Libtayo |
| Mimedx Group, INC. | $37.40 | 2024 | |
| Ucb, INC. | $28.30 | 2025 | Bimzelx |
| Janssen Biotech, INC. | $19.11 | 2023 | Tremfya |
| Lilly USA, LLC | $17.04 | 2022 | |
| Medline Industries LP | $12.83 | 2020 | |
| Lifenet Health | $10.01 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hollabaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.